Wellstar International, Inc. (WLSI.OB) Announces Success in Beta Test for Long-Term Care Facilities
Wellstar International Inc., through its wholly-owned subsidiary, Trillennium Medical Imaging, develops and licenses the use of advanced thermal imaging technology in consumer health care markets worldwide. The company's TMI infrared technology and software is approved by the United States Food and Drug Administration (FDA) as an adjunctive diagnostic screening procedure for early breast cancer detection, orthopedic applications, pain dysfunctions, deep tissue injuries and detection of pressure ulcers. The company announced today that it is achieving success in its beta test in a long-term acute care facility (LTAC). Wellstar has been imaging existing and newly admitted patients twice a week in…